Article Text

PDF
Commentary
  1. D Goldmeier1,
  2. D Richardson2
  1. 1
    Imperial College NHS Trust at St Mary’s Hospital, London, UK
  2. 2
    Lawson Unit Royal Sussex County Hospital, Brighton, UK
  1. Dr David Goldmeier, Imperial College NHS Trust at St Mary’s Hospital, London W2 1NY, UK; david.goldmeier{at}imperial.nhs.uk

Statistics from Altmetric.com

The article by Crosby and colleagues1 in the current edition of the journal suggests that the use of phosphodiesterase 5 inhibitors (PDE5i) (sildenafil, tadalafil and vardenafil) by men is associated with a significantly increased rate of condom breakage compared with men who use condoms but not PDE5i. This seems biologically plausible in that whatever the degree of a man’s natural penile rigidity, PDE5i use can enhance that intensity of tumescence.2

The use of PDE5i in HIV and other sexually transmitted infection (STI) acquisition and transmission is of importance, particularly in men who have sex with men (MSM). In clinical practice it would seem logical …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Brief encounters
    Helen Ward Rob Miller